BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28499710)

  • 1. Impact of prealbumin on mortality and hospital readmission in patients with acute heart failure.
    Franco J; Formiga F; Trullas JC; Salamanca Bautista P; Conde A; Manzano L; Quirós R; Franco ÁG; Ezquerro AM; Montero-Pérez-Barquero M;
    Eur J Intern Med; 2017 Sep; 43():36-41. PubMed ID: 28499710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low prealbumin is strongly associated with adverse outcome in heart failure.
    Lourenço P; Silva S; Friões F; Alvelos M; Amorim M; Couto M; Torres-Ramalho P; Guimarães JT; Araújo JP; Bettencourt P
    Heart; 2014 Nov; 100(22):1780-5. PubMed ID: 24986895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of potassium levels on one-year outcomes in elderly patients with acute heart failure.
    Formiga F; Chivite D; Corbella X; Conde-Martel A; Arévalo-Lorido JC; Trullàs JC; Silvestre JP; García SC; Manzano L; Montero-Pérez-Barquero M;
    Eur J Intern Med; 2019 Feb; 60():24-30. PubMed ID: 30722845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of short-term follow-up BNP in hospitalized patients with heart failure.
    Khanam SS; Son JW; Lee JW; Youn YJ; Yoon J; Lee SH; Kim JY; Ahn SG; Ahn MS; Yoo BS
    BMC Cardiovasc Disord; 2017 Aug; 17(1):215. PubMed ID: 28774268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of comorbidities in hospitalized patients with acute exacerbation of chronic heart failure.
    Scrutinio D; Passantino A; Guida P; Ammirati E; Oliva F; Braga SS; La Rovere MT; Lagioia R; Frigerio M
    Eur J Intern Med; 2016 Oct; 34():63-67. PubMed ID: 27263064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyponatremia as predictor of worse outcome in real world patients admitted with acute heart failure.
    Arévalo Lorido JC; Carretero Gómez J; Formiga F; Montero Pérez-Barquero M; Trullás Vila JC; Aramburu Bodas O; Ceresuela LM;
    Cardiol J; 2013; 20(5):506-12. PubMed ID: 24469874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale and design of PRIMA II: A multicenter, randomized clinical trial to study the impact of in-hospital guidance for acute decompensated heart failure treatment by a predefined NT-PRoBNP target on the reduction of readmIssion and Mortality rAtes.
    Stienen S; Salah K; Moons AH; Bakx AL; van Pol PE; Schroeder-Tanka JM; Voogel AJ; Keijer JT; Kortz RA; Dickhoff C; Meregalli PG; Tijssen JG; Pinto YM; Kok WE
    Am Heart J; 2014 Jul; 168(1):30-6. PubMed ID: 24952857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and prognostic impact of frailty and its components in non-dependent elderly patients with heart failure.
    Vidán MT; Blaya-Novakova V; Sánchez E; Ortiz J; Serra-Rexach JA; Bueno H
    Eur J Heart Fail; 2016 Jul; 18(7):869-75. PubMed ID: 27072307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk stratification with the use of serial N-terminal pro-B-type natriuretic peptide measurements during admission and early after discharge in heart failure patients: post hoc analysis of the PRIMA study.
    Eurlings LW; Sanders-van Wijk S; van Kraaij DJ; van Kimmenade R; Meeder JG; Kamp O; van Dieijen-Visser MP; Tijssen JG; Brunner-La Rocca HP; Pinto YM
    J Card Fail; 2014 Dec; 20(12):881-90. PubMed ID: 25175696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart failure mortality according to acute variations in N-terminal pro B-type natriuretic peptide and cystatin C levels.
    Carrasco-Sánchez FJ; Pérez-Calvo JI; Morales-Rull JL; Galisteo-Almeda L; Páez-Rubio I; Barón-Franco B; Aguayo-Canela M; Pujol-De la llave E
    J Cardiovasc Med (Hagerstown); 2014 Feb; 15(2):115-21. PubMed ID: 24522084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European coLlaboration on Acute decompeNsated Heart Failure: ELAN-HF Score.
    Salah K; Kok WE; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Bayes-Genis A; Verdiani V; Bettari L; Lazzarini V; Damman P; Tijssen JG; Pinto YM
    Heart; 2014 Jan; 100(2):115-25. PubMed ID: 24179162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 30-day metric in acute heart failure revisited: data from IN-HF Outcome, an Italian nationwide cardiology registry.
    Di Tano G; De Maria R; Gonzini L; Aspromonte N; Di Lenarda A; Feola M; Marini M; Milli M; Misuraca G; Mortara A; Oliva F; Pulignano G; Russo G; Senni M; Tavazzi L;
    Eur J Heart Fail; 2015 Oct; 17(10):1032-41. PubMed ID: 26018852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics and predictors of in-hospital mortality in 270 consecutive patients hospitalised due to acute heart failure in a single cardiology centre during one year.
    Biegus J; Zymliński R; Szachniewicz J; Siwołowski P; Pawluś A; Banasiak W; Jankowska EA; Ponikowski P
    Kardiol Pol; 2011; 69(10):997-1005. PubMed ID: 22006596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
    Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
    Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of High-Sensitivity Troponin T to Identify Patients With Acute Heart Failure at Lower Risk for Adverse Outcomes: An Exploratory Analysis From the RELAX-AHF Trial.
    Pang PS; Teerlink JR; Voors AA; Ponikowski P; Greenberg BH; Filippatos G; Felker GM; Davison BA; Cotter G; Kriger J; Prescott MF; Hua TA; Severin T; Metra M
    JACC Heart Fail; 2016 Jul; 4(7):591-599. PubMed ID: 27039129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic implications of prealbumin level on admission in patients with acute heart failure referred to a cardiac intensive care unit.
    Akashi M; Minami Y; Haruki S; Jujo K; Hagiwara N
    J Cardiol; 2019 Feb; 73(2):114-119. PubMed ID: 30366636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute changes in N-terminal pro-B-type natriuretic peptide during hospitalization and risk of readmission and mortality in patients with heart failure.
    Michtalik HJ; Yeh HC; Campbell CY; Haq N; Park H; Clarke W; Brotman DJ
    Am J Cardiol; 2011 Apr; 107(8):1191-5. PubMed ID: 21296322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study.
    Berger R; Moertl D; Peter S; Ahmadi R; Huelsmann M; Yamuti S; Wagner B; Pacher R
    J Am Coll Cardiol; 2010 Feb; 55(7):645-53. PubMed ID: 20170790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of hand-carried ultrasound assessment of the inferior vena cava and N-terminal pro-brain natriuretic peptide for predicting readmission after hospitalization for acute decompensated heart failure.
    Goonewardena SN; Gemignani A; Ronan A; Vasaiwala S; Blair J; Brennan JM; Shah DP; Spencer KT
    JACC Cardiovasc Imaging; 2008 Sep; 1(5):595-601. PubMed ID: 19356487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of brain natriuretic peptide in acute heart failure: mortality and hospital readmission.
    Núñez J; Núñez E; Robles R; Bodí V; Sanchis J; Carratalá A; Aparici M; Llàcer A
    Rev Esp Cardiol; 2008 Dec; 61(12):1332-7. PubMed ID: 19080974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.